Rite Aid Corporation (NYSE:RAD) announced sales results for April. Monthly Sales For the four weeks ended April 26, 2014, same store sales increased 5.0 percent over the prior-year period. April front-end same store sales increased 4.7 percent, with 4.6 percent of the increase attributable to a shift in the timing of Easter, which fell on April 20 this year compared to March 31 last year. Pharmacy same store sales, which included an approximate 138 basis points negative impact from new generic introductions, increased 5.2 percent. Prescription count at comparable stores increased 2.3 percent over the prior-year period. Rite Aid Corporation (NYSE:RAD) shares after opening at $7.42 moved to $7.90 on last trade day and at the end of the day closed at $7.70 . Company price to sales ratio in past twelve months was calculated as 0.29 and price to cash ratio as 51.11. Rite Aid Corporation (NYSE:RAD) showed a positive weekly performance of 8.15%.
Merrimack Pharmaceuticals Inc (NASDAQ:MACK) said Thursday that patients treated with its experimental pancreatic cancer drug lived longer than patients who received only standard chemotherapy. Merrimack Pharmaceuticals Inc (NASDAQ:MACK) shares advanced 59.23% in last trading session and ended the day on $6.99. MACK return on equity ratio is recorded as 349.10% and its return on assets is -80.40 %. Merrimack Pharmaceuticals Inc (NASDAQ:MACK) yearly performance is 55.33%.
Micron Technology, Inc. (NASDAQ:MU)’s management remarked in company’s earnings call that Micron is expecting strong revenue growth in coming years. Micron is hence marching towards the development of hybrid memory computing stacked with key server customers. The specific tool is designed for facilitating the working of applications requiring high-bandwidth access. It further boosts buffering, storage and computing application including processor acceleration. HMC provides 160 GB/second of memory bandwidth. Micron Technology, Inc. (NASDAQ:MU) shares moved up 0.50% in last trading session and was closed at $26.25 while trading in range of $25.85 – $26.82 – Micron Technology, Inc. (NASDAQ:MU) year to date (YTD) performance is 20.69%.
AstraZeneca’s plc (ADR) (NYSE:AZN) shares soared 12.16% after a statement was released by Pfizer (PFE) confirming that it had discussions with the former regarding a possible merger. Pfizer confirmed that in Jan 2014, it had submitted a preliminary, non-binding and conditional proposal regarding a possible offer for AstraZeneca. AstraZeneca plc (ADR) (NYSE:AZN) weekly performance is 17.50%. On last trading day company shares ended up $81.09. AstraZeneca plc (ADR) (NYSE:AZN) distance from 50-day simple moving average (SMA50) is 21.92%. Analysts mean target price for the company is $70.05.